Published in Hepatitis Weekly, May 18th, 1998
Researcher Philippe Mathurin and colleagues found that the progression to fibrosis was twice as slow in hepatitis C virus (HCV) patients with normal alanine aminotransferase (ALT) as in HCV patients with elevated ALTs.
"We suggest that the natural history of HCV infection in patients with persistently normal ALT is associated with a low risk of developing severe liver lesions, especially in patients without alcohol consumption," Mathurin et al. wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.